107 related articles for article (PubMed ID: 18251184)
1. High DcR3 expression predicts stage pN2 in gastric cancer.
Wu Y; Guo E; Yu J; Xie Q; Chen J
Hepatogastroenterology; 2007; 54(79):2172-6. PubMed ID: 18251184
[TBL] [Abstract][Full Text] [Related]
2. High DcR3 expression predicts stage pN2-3 in gastric cancer.
Wu Y; Guo E; Yu J; Xie Q
Am J Clin Oncol; 2008 Feb; 31(1):79-83. PubMed ID: 18376232
[TBL] [Abstract][Full Text] [Related]
3. Ascites from epithelial ovarian cancer contain high levels of functional decoy receptor 3 (DcR3) and is associated with platinum resistance.
Connor JP; Felder M
Gynecol Oncol; 2008 Nov; 111(2):330-5. PubMed ID: 18723214
[TBL] [Abstract][Full Text] [Related]
4. Serum HDL-C as a potential biomarker for nodal stages in gastric cancer.
Guo E; Chen L; Xie Q; Chen J; Tang Z; Wu Y
Ann Surg Oncol; 2007 Sep; 14(9):2528-34. PubMed ID: 17597347
[TBL] [Abstract][Full Text] [Related]
5. Gastric cancer: correlation between clinicopathological factors and survival of patients (III).
Lazăr D; Tăban S; Sporea I; Dema A; Cornianu M; Lazăr E; Goldiş A; Vernic C
Rom J Morphol Embryol; 2009; 50(3):369-79. PubMed ID: 19690762
[TBL] [Abstract][Full Text] [Related]
6. Metastatic lymph node ratio is an independent prognostic factor in gastric cancer.
Asoglu O; Karanlik H; Parlak M; Kecer M; Muslumanoglu M; Igci A; Ozmen V; Gulluoglu M; Kapran Y
Hepatogastroenterology; 2009; 56(91-92):908-13. PubMed ID: 19621727
[TBL] [Abstract][Full Text] [Related]
7. High epidermal growth factor receptor expression in metastatic colorectal cancer lymph nodes may be more prognostic of poor survival than in primary tumor.
Deng Y; Kurland BF; Wang J; Bi J; Li W; Rao S; Lan P; Lin T; Lin E
Am J Clin Oncol; 2009 Jun; 32(3):245-52. PubMed ID: 19451802
[TBL] [Abstract][Full Text] [Related]
8. The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and patient outcome.
Tsamandas AC; Kardamakis D; Tsiamalos P; Liava A; Tzelepi V; Vassiliou V; Petsas T; Vagenas K; Zolota V; Scopa CD
Anticancer Res; 2009 Feb; 29(2):703-9. PubMed ID: 19331225
[TBL] [Abstract][Full Text] [Related]
9. Decoy receptor 3 levels in peripheral blood predict outcomes of acute respiratory distress syndrome.
Chen CY; Yang KY; Chen MY; Chen HY; Lin MT; Lee YC; Perng RP; Hsieh SL; Yang PC; Chou TY
Am J Respir Crit Care Med; 2009 Oct; 180(8):751-60. PubMed ID: 19644047
[TBL] [Abstract][Full Text] [Related]
10. The prognostic significance of overexpression of the decoy receptor for Fas ligand (DcR3) in patients with gastric carcinomas.
Takahama Y; Yamada Y; Emoto K; Fujimoto H; Takayama T; Ueno M; Uchida H; Hirao S; Mizuno T; Nakajima Y
Gastric Cancer; 2002; 5(2):61-8. PubMed ID: 12111580
[TBL] [Abstract][Full Text] [Related]
11. Expression of a soluble decoy receptor 3 in patients with diffuse large B-cell lymphoma predicts clinical outcome.
Chang PM; Chen PM; Hsieh SL; Tzeng CH; Liu JH; Chiou TJ; Wang WS; Yen CC; Gau JP; Yang MH
Int J Oncol; 2008 Sep; 33(3):549-54. PubMed ID: 18695885
[TBL] [Abstract][Full Text] [Related]
12. Expression of decoy receptor 3 in liver tissue microarrays.
Chen G; Luo D
Natl Med J India; 2008; 21(6):275-8. PubMed ID: 19691215
[TBL] [Abstract][Full Text] [Related]
13. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.
Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH
Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246
[TBL] [Abstract][Full Text] [Related]
14. Functional characterisation of decoy receptor 3 in Crohn's disease.
Funke B; Autschbach F; Kim S; Lasitschka F; Strauch U; Rogler G; Gdynia G; Li L; Gretz N; Macher-Goeppinger S; Sido B; Schirmacher P; Meuer SC; Roth W
Gut; 2009 Apr; 58(4):483-91. PubMed ID: 19039087
[TBL] [Abstract][Full Text] [Related]
15. Prediction of treatment outcome by CD44v6 after total mesorectal excision in locally advanced rectal cancer.
Peng J; Lu JJ; Zhu J; Xu Y; Lu H; Lian P; Cai G; Cai S
Cancer J; 2008; 14(1):54-61. PubMed ID: 18303484
[TBL] [Abstract][Full Text] [Related]
16. PAI-1 expression levels in gastric cancers are closely correlated to those in corresponding normal tissues.
Sakakibara T; Hibi K; Koike M; Fujiwara M; Kodera Y; Ito K; Nakao A
Hepatogastroenterology; 2008; 55(85):1480-3. PubMed ID: 18795717
[TBL] [Abstract][Full Text] [Related]
17. Impact of total retrieved lymph nodes on staging and survival of patients with gastric cancer invading the subserosa.
Liu C; Lu Y; Jun Z; Zhang R; Yao F; Lu P; Jin F; Li H; Xu H; Wang S; Chen J
Surg Oncol; 2009 Dec; 18(4):379-84. PubMed ID: 18954972
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of insulin-like growth factor II mRNA-binding protein 3 expression in gastric adenocarcinoma.
Jeng YM; Wang TH; Lu SH; Yuan RH; Hsu HC
Br J Surg; 2009 Jan; 96(1):66-73. PubMed ID: 19109797
[TBL] [Abstract][Full Text] [Related]
19. Over-expression of decoy receptor 3 in gastric precancerous lesions and carcinoma.
Chen G; Luo D
Ups J Med Sci; 2008; 113(3):297-304. PubMed ID: 18991242
[TBL] [Abstract][Full Text] [Related]
20. Nodal staging in adenocarcinoma of the gastro-esophageal junction. Proposal of a specific staging system.
Pedrazzani C; deManzoni G; Marrelli D; Giacopuzzi S; Corso G; Bernini M; Roviello F
Ann Surg Oncol; 2007 Feb; 14(2):299-305. PubMed ID: 17146743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
